Yuto Takebayashi
Juntendo University(JP)
Publications by Year
Research Areas
Tryptophan and brain disorders, Amino Acid Enzymes and Metabolism, Schizophrenia research and treatment, Genetics and Neurodevelopmental Disorders, Alzheimer's disease research and treatments
Most-Cited Works
- → Benefits of use, and tolerance of, medium-chain triglyceride medical food in the management of Japanese patients with Alzheimer’s disease: a prospective, open-label pilot study(2016)77 cited
- → Estimated cognitive decline in patients with schizophrenia: A multicenter study(2016)68 cited
- → Significance of Measurements of Peripheral Carbonyl Stress Markers in a Cross-sectional and Longitudinal Study in Patients With Acute-stage Schizophrenia(2014)40 cited
- → Association study between Disrupted-in-Schizophrenia-1 (DISC1) and Japanese patients with treatment-resistant schizophrenia (TRS)(2011)29 cited
- → Altered serum glyceraldehyde-derived advanced glycation end product (AGE) and soluble AGE receptor levels indicate carbonyl stress in patients with schizophrenia(2015)23 cited
- → No Correlation between Plasma NMDA-Related Glutamatergic Amino Acid Levels and Cognitive Function in Medicated Patients with Schizophrenia(2012)15 cited
- → Medium‐chain triglycerides given in the early stage of mild‐to‐moderate Alzheimer's disease enhance memory function(2017)15 cited
- → High serum soluble tumor necrosis factor receptor 1 predicts poor treatment response in acute-stage schizophrenia(2017)15 cited
- → No association between glutathione‐synthesis‐related genes and Japanese schizophrenia(2010)14 cited
- → No associations found between the genes situated at 6p22.1, HIST1H2BJ, PRSS16, and PGBD1 in Japanese patients diagnosed with schizophrenia(2012)11 cited